Absence of sensory neuropathy among workers with occupational exposure to chlorpyrifos

Muscle and Nerve

Volumn 29, Issue 5, 2004, Pages 677-686

  Albers, James W ^a,b   Garabrant, David H ^b   Schweitzer, Sarah ^b   Garrison, Richard P ^b   Richardson, Rudy J ^a,b   Berent, Stanley ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chlorpyrifos; Insecticides; Nervous system; Neuropathy; Neurotoxicity

Indexed keywords

CHLORPYRIFOS; CHOLINESTERASE; CREATININE; ORGANOPHOSPHATE INSECTICIDE; PYRIDINOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SENSORY NEUROPATHY; WORKER;

ADOLESCENT; ADULT; AGED; CHEMICAL INDUSTRY; CHI-SQUARE DISTRIBUTION; CHLORPYRIFOS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; OCCUPATIONAL DISEASES; POLYRADICULONEUROPATHY;

EID: 2442604717     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20007     Document Type: Article

References (48)

1. Albers JW, Brown MB, Sima AAF, Greene DA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Muscle Nerve 1996;19:140-146.
2. Albers JW, Cavender GF, Levine SP, Langolf GD. Asymptomatic sensorimotor polyneuropathy in workers exposed to elemental mercury. Neurology 1982;32:1168-1174.
3. Albers JW, Cole P, Greenberg RS, Mandel JS, Monson RR, Ross JH, Snodgrass WR, Spurgeon A, van Gemert M. Analysis of chlorpyrifos exposure and human health: expert panel report. J Toxicol Environ Health Part B Crit Rev 1999;2:301-324.
4. Albers JW, Garabrant DH, Schweitzer SJ, Garrison RP, Richardson RJ, Berent S. The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort study. Environ Occup Med (in press)
5. Albers JW, Wald JJ, Werner RA, Franzblau A, Berent S. Absence of polyneuropathy among workers previously diagnosed with solvent-induced toxic encephalopathy. J Occup Environ Med 1999;41:500-509.
6. Ames RG, Steenland K, Jenkins B, Chrislip D, Russo J. Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch Environ Health 1995;50:440-444.
7. Beach JR, Spurgeon A, Stephens R, Heafield T, Calvert IA, Levy LS, Harrington JM. Abnormalities on neurological examination among sheep farmers exposed to organophosphorous pesticides. Occup Environ Med 1996;53:520-525.
8. Blain PG. Adverse health effects after low dose exposure to organophosphates. Occup Environ Med 2001;58:689-690.
9. Burns CJ, Cartmill JB, Powers BS, Lee MK. An update of the morbidity experience among employees potentially exposed to chlorpyrifos. Occup Environ Med 1998;55:65-70.
10. Capodicasa E, Scapellato ML, Moretto A, Caroldi S, Lotti M. Chlorpyrifos-induced delayed polyneuropathy. Arch Toxicol 1991;65:150-155.
11. Clegg DJ, van Gemert M. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. J Toxicol Environ Health B Crit Rev 1999;2:257-279.
12. Cochran RC. Appraisal of risks from nonoccupational exposure to chlorpyrifos. Regul Toxicol Pharmacol 2002;35:105-121.
13. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880.
14. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetic therapy on the development and progression of neuropathy. Ann Intern Med 1995;122: 561-568.
15. Dyck PJ. Peripheral neuropathy. Changing concepts, differential diagnosis and classification. Med Clin N Am 1968;52: 895-908.
16. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetes. Muscle Nerve 1988;11:21-32.
17. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-1121.
18. Gotoh M, Saito S, Huang J, Fukaya Y, Matsumoto T, Hisanaga N, Shibata E, Ichihara G, Kamijima M, Takeuchi Y. Changes in cholinesterase activity, nerve conduction velocity, and clinical signs and symptoms in termite control operators exposed to chlorpyrifos. J Occup Health 2001;43:157-164.
19. Greene DA, Sima AF, Pfeifer MA, Albers JW. Diabetic neuropathy. Annu Rev Med 1990;41:303-517.
20. Gutmann L, Besser R. Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations. Semin Neurol 1990;10:46-51.
21. Hill RH Jr, Head SL, Baker S, Gregg M, Shealy DB, Bailey SL, Williams CC, Sampson EJ, Needham LL. Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 1995;71:99-108.
22. Jamal GA, Hansen S, Pilkington A, Buchanan D, Gillham RA, Abdel-Azis M, Julu PO, Al Rawas SF, Hurley F, Ballantyne JP. A clinical neurological, neurophysiological, and neuropsychological study of sheep farmers and dippers exposed to organophosphate pesticides. Occup Environ Med 2002;59: 434-441.
23. Kaplan JG, Rosenberg NL, Pack D, Schaumburg HH. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology 1993;43:2193-2196.
24. Letz R, Gerr F. Covariates of human peripheral nerve function: I-nerve conduction velocity and amplitude. Neurotoxicol Teratol 1994;16:95-104.
25. Linz DH, Suskind RR, Lockey JE, Keebler PJ, Shukla R, Rice CH, Pflaumer JE, McKay RT, Livingston GK, Albert RE. Health status of pesticide applicators with attention to the peripheral nervous system. J Argomed 1994;1:23-42.
26. London L, Nell V, Thompson ML, Myers JE. Effects of long-term organophosphate exposures on neurological symptoms, vibration sense and tremor among South African farm workers. Scand J Work Environ Health 1998;24:18-29.
27. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol 1991;21:465-487.
28. Lotti M. Low-level exposures to organophosphorus esters and peripheral nerve function. Muscle Nerve 2002;25:492-504.
29. Latti M, Becker CE, Aminoff MJ. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 1984;34: 658-662.
30. Lotti M, Moretto A, Zoppellari R, Dainese R, Rizzuto N, Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol 1986;59:176-179.
31. Moretto A, Lotti M. Poisoning by organophosphorus insecticides and sensory neuropathy. J Neurol Neurosurg Psychiatry 1998;64:463-468.
32. Pilkington A, Buchanan D, Jamal CA, Gillham R, Hansen S, Kidd M, Hurley JF, Soutar CA. An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med 2001;58:702-710.
33. Redmond JM, McKenna MJ, Feingold M, Ahmad BK. Sensory testing versus nerve conduction velocity in diabetic polyneuropathy. Muscle Nerve 1992;15:1334-1339.
34. Redmond MD, Rivner MH. False positive electrodiagnostic tests in carpal tunnel syndrome. Muscle Nerve 1988;11:511-517.
35. Richardson RJ. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health 1995;44:135-165.
36. Robinson LR, Micklesen BS, Wang L. Strategies for analyzing nerve conduction data: superiority of a summary index over single tests. Muscle Nerve 1998;21:1166-1171.
37. Salerno DF, Franzblau A, Werner RA, Bromberg MB, Armstrong TJ, Albers JW. Median and ulnar nerve conduction studies among workers: normative values. Muscle Nerve 1998; 21:999-1005.
38. Salerno DF, Werner RA, Albers JW, Becker MP, Armstrong TJ, Franzblau A. Reliability of nerve conduction studies among active workers. Muscle Nerve 1999;22:1372-1379.
39. Senanayake N, Johnson MK. Acute polyneuropathy after poisoning by a new organophosphate insecticide. N Engl J Med 1982;306:155-157.
40. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898-904.
41. Steentand K, Jenkins B, Ames RG, O'Malley M, Chrislip D, Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Pubt Health 1994;84:731-736.
42. Steenland K, Jenkins B, Ames RG, O'Malley M, Chrislip D, Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Publ Health 1994;84:731-736.
43. Stetson DS, Albers JW, Silverstein BA, Wolfe RA. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve 1992;15:1095-1104.
44. Stetson DS, Silverstein BA, Keyserling WM, Wolfe RA, Albers JW. Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Indust Med 1993;24:175-189.
45. Stokes L, Stark A, Marshall E, Narang A. Neurotoxicity among pesticide applicators exposed to organophosphates. Occup Environ Med 1995;52:648-653.
46. Werner RA, Franzblau A, Albers JW, Armstrong TJ. Median mononeuropathy among active workers: are there differences between symptomatic and asymptomatic workers? Am J Indust Med 1998;33:374-378.
47. Wilbourn AJ. Sensory nerve conduction studies. J Clin Neurophysiol 1994;11:584-601.
48. Woods HF, and the Working Group on Organophosphates. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Department of Health, United Kingdom; 1999. p 1-7.